OSTEOPATHIC BOARD CERTIFICATION

Back to AOA CBS

AOA Specialty Certifying Boards

AOA Conjoint Examination Committees

Other Recognitions

Longitudinal Assessment References

Due to copyright restrictions, the PAAI CCEC cannot provide most reference materials used for longitudinal assessment. However, a list of the references used for the 2025 longitudinal assessment can be found below. Hyperlinks are provided in teal text where applicable.

Exam references

2026 references
  • American Journal of Speech-Language Pathology (Jul 2023); Vol. 32, Issue 4; Therapy outcomes for teenage athletes with exercise-induced laryngeal obstruction; pg. 1517-1531
  • Singapore Medical Journal (Apr 2008); Vol. 49, Issue 4; Paradoxical vocal cord dysfunction: when a wheeze is not asthma; pg. 110-112
  • The Physician and Sportsmedicine (May 2012); Vol. 40, Issue 2; Vocal cord dysfunction in athletes: clinical presentation and review of the literature; pg. 22-27
  • Advances in Therapy (Jan 2023); Vol. 40, Issue 1; A review of anti-IL-5 therapies for eosinophilic granulomatosis with polyangiitis; pg. 25-40
  • Current Opinion in Allergy and Clinical Immunology (Feb 2023); Vol. 23, Issue 1; Biologics for eosinophilic granulomatosis with polyangiitis; pg. 36-43
  • Journal of Clinical Medicine (Sep 2023); Vol. 12, Issue 18; Eosinophilic granulomatosis with polyangiitis: latest findings and updated treatment recommendations
  • Trends in Microbiology (Sep 2023); Vol. 31, Issue 9; Masking of typical TLR4 and TLR5 ligands modulates inflammation and resolution by Helicobacter pylori; pg. 903-915
  • Current Topics in Microbiology and Immunology (2023); Vol. 444; Immune biology and persistence of Helicobacter pylori in gastric diseases; pg. 83-115
  • McCance & Huether’s Pathophysiology, 9th ed. (2020); Ch. 74; pg. 1216-1227
  • Journal of Clinical Immunology (Jun 2024); Vol. 44, Issue 6; An exploratory approach of clinically useful biomarkers of CVID by logistic regression; pg. 143
  • European Annals of Allergy and Clinical Immunology (Oct 2024); Different clinical phenotypes in common variable immunodeficiency
  • Critical Reviews in Clinical Laboratory Sciences (Mar 2025); Vol. 62, No. 2; The role of immunophenotyping in common variable immunodeficiency: a narrative review; pg. 65-84
  • Casopis Lekaru Ceskych (2022); Vol. 161, Issue 1; Current treatment options for monogenic periodic fever syndromes – the role of interleukin 1 inhibitors; pg. 3-10
  • Frontiers in Immunology (Feb 2021); Vol. 11; IL-1 inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives
  • Missouri Medicine (Sep 2024); Vol. 121, Issue 5; Update on asthma management guidelines; pg. 364-367
  • Global Initiative for Asthma (Updated 2025); 2025 global strategy for asthma management and prevention
  • American Journal of Respiratory and Critical Care Medicine (Jan 2005); Vol. 171, Issue 2; Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma; pg. 129-136
  • The Journal of Allergy and Clinical Immunology: In Practice (Mar 2023); Vol. 11, Issue 3; The ICS/formoterol reliever therapy regimen in asthma: a review; pg. 762-772.e1
  • JAMA Dermatology (Nov 2019); Vol. 156, Issue 1; Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis; pg. 44-56
  • DermNet (Updated Mar 2019); Porphyria cutanea tarda
  • NIH (Updated May 2025); Porphyria cutanea tarda
  • Pediatric Allergy and Immunology: Official Publication of the European Society of Pediatric Allergy and Immunology (Mar 2025); Vol. 36, Issue 3; An update on the diagnosis and management of non-IgE-mediated food allergies in children; pg. E70060
  • Journal of Allergy and Clinical Immunology (Apr 2017); Vol. 139, Issue 4; International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: executive summary—Workgroup Report of the Adverse Reactions to Foods Committee
  • American Academy of Allergy, Asthma & Immunology; pg. 1111-1126.e4
  • Middleton’s Allergy, 9th ed. (2020)
    • Ch. 65; pg. 1075-1085
    • Ch. 40; Box 40.1; pg. 638-658
    • Ch. 40; Table 40.2
2025 references
  • American Journal of Respiratory and Critical Care Medicine (Jun 1997); Vol. 155, Issue 6; Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response; pg. 1835-1840. https://pubmed.ncbi.nlm.nih.gov/9196083/
  • Annual Review of Immunology (Apr 2018); Vol. 36; Signaling and function of interleukin-2 in T lymphocytes; pg. 411-413
  • Biologics: Targets & Therapy (Feb 2021); Vol. 15; Biologic treatments of psoriasis: an update for the clinician; pg. 39-51
  • Cells (Oct 2021); Vol. 10, Issue 10; Plectin in skin fragility disorders; pg. 2738
  • Chest (Mar 2009); Vol. 135, Issue 3; Allergic bronchopulmonary aspergillosis; pg. 805-826. https://doi.org/10.1378/chest.08-2586
  • Clinical & Experimental Allergy (Jan 2021); Vol. 51, Issue 1; Asthma and fixed airflow obstruction: long-term trajectories suggest distinct endotypes; pg. 39-48
  • Clinical and Experimental Immunology (Jun 2000); Vol. 120, Issue 3; X-linked immunodeficiency with hyper-IgM (XHIM); pg. 399-405
  • Clinical Immunology and Immunopathology (Nov 1989); Vol. 53, Issue 2; Human IgG Fc receptors; pg. S63-S71
  • Clinical Medicine (London) (Aug 2009); Vol. 9, Issue 4; Pemphigus: a brief review; pg. 371-375
  • Clinics in Dermatology (Jan 2006); Vol. 24, Issue 5; Dermatomyositis; pg. 363-373
  • Cureus (Apr 2023); Vol. 15, Issue 4; The curious case of elevated tryptase: workup and differential in family of four
  • Cureus (Oct 2022); Vol. 14, Issue 10; An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management; pg. e30330
  • Expert Review of Respiratory Medicine (Dec 2016); Vol. 10, Issue 12; Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis; pg. 1317-1334. https://pubmed.ncbi.nlm.nih.gov/27744712/
  • Faculty Reviews (Sep 2021); Vol. 10; Recent advances in understanding the role of IL-4 signaling; pg. 71
  • Frontiers in Immunology (Apr 2018); Vol. 9; Autoantibody signaling in pemphigus vulgaris: development of an integrated model; pg. 692
  • Frontiers in Physiology (May 2022); Vol. 13; Fixed airflow obstruction in asthma: a problem of the whole lung not of just the airwaysJournal of Personalized Medicine (Feb 2022); Vol. 12, Issue 3; Asthma with fixed airflow obstruction: from fixed to personalized approach
  • GeneReviews (Updated Aug 2021); X-linked severe combined immunodeficiency. https://www.ncbi.nlm.nih.gov/books/NBK1410/
  • Hematology, the ASH Education Program (Dec 2016); Vol. 2016, Issue 1; Primary immune deficiencies with defects in neutrophil function; pg. 43-50
  • Human Immunology (Jun 2019); Vol. 80, Issue 6; Primary B-cell immunodeficiencies; pg. 351-362
  • Immunological Reviews (Jan 2018); Vol. 281, Issue 1; Overview of the IL-1 family in innate inflammation and acquired immunity; pg. 8-27
  • Immunology and Allergy Clinics of North American (Aug 2020); Vol. 40, Issue 3; The importance of primary immune deficiency registries: The United States Immunodeficiency Network Registry; pg. 385-402
  • Immunotherapy (Jan 2024); Vol. 16, Issue 1; Epicutaneous immunotherapy with Viaskin™ peanut in toddlers: a plain language summary; pg. 5-13
  • Indian Journal of Dermatology (Jan 2010); Vol. 55, Issue 2; Biological therapy of psoriasis; pg. 161-170
  • Indian Journal of Dermatology (Sep 2012); Vol. 57, Issue 5; Clinical presentation and evaluation of dermatomyositis; pg. 375-381
  • International Archives of Allergy and Immunology (Jan 2015); Vol. 168, Issue 3; Influence of omalizumab on allergen-specific IgE in patients with adult asthma; pg. 165-172
  • International Journal of Women’s Dermatology (Jul 2019); Vol. 5, Issue 5; Cutaneous lupus erythematosus: a review of the literature; pg. 320-329
  • Journal of Allergy and Clinical Immunology (Apr 2017); Vol. 139, Issue 4; International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology; pg. 1111-1126
  • Journal of Blood Medicine (Dec 2023); Vol. 14; Paroxysmal nocturnal hemoglobinuria: current management, unmet needs, and recommendations; pg. 613-628
  • Journal of Clinical Immunology (Nov 2023); Vol. 43, Issue 8; Respiratory comorbidities associated with bronchiectasis in patients with common variable immunodeficiency in the USIDNET registry; pg. 2208-2220
  • Journal of the American Academy of Dermatology (Feb 2024); Clinical characteristics and symptom progression of dermatomyositis subtypes: a retrospective analysis of a prospective database
  • Middleton’s Allergy Principles and Practice, 9th edition (2020); Figure 65.2
  • Pediatrics (Dec 2023); Vol. 152, Suppl 3; Albuterol-budesonide fixed-dose combination rescue inhaler for asthma; pg. S52
  • Periodontal (May 1993); Issue 64, Suppl. 5; The role of interleukin-8 in inflammation and mechanisms of regulation; pg. 456-460
  • Pharmacology & Therapeutics (Mar 2021); Interleukin-8: a chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression
  • PloS One (Feb 2020); Vol. 15, Issue 2; The association between allergic rhinitis and sleep: a systematic review and meta-analysis of observational studies
  • Proceedings of the Japan Academy, Series B: Physical and Biological Sciences (Oct 2011); Vol. 87, Issue 8; Interleukin-5 and IL-5 receptor in health and diseases; pg. 463-485
  • Respiratory Medicine (Mar 2001); Vol. 95, Issue 3; Respiratory disorders in common variable immunodeficiency; pg. 191-195
  • Scientific Reports (Oct 2023); Vol. 13, Issue 1; Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry
  • StatPearls (Updated Jul 2023); X-linked agammaglobulinemia. https://www.ncbi.nlm.nih.gov/books/NBK549865/
  • The Indian Journal of Medical Research (Jun 2020); Vol. 151, Issue 6; Allergic bronchopulmonary aspergillosis; pg. 529-549. https://doi.org/10.4103/ijmr.IJMR_1187_19
  • The Journal of Allergy and Clinical Immunology (Jan 2024); Vol. 153, Issue 1; Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: a randomized, placebo-controlled trial; pg. 173-181
  • The Journal of Allergy and Clinical Immunology (Jul 1984); Vol. 74, Issue 1; Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis; pg. 68-71. https://doi.org/10.1016/0091-6749(84)90089-7
  • The Journal of Allergy and Clinical Immunology: In Practice (Jan 2024); Vol. 12, Issue 1; Long-term follow-up of children who achieved sustained unresponsiveness after peanut oral immunotherapy; pg. 255-256
  • The Journal of Clinical and Aesthetic Dermatology (Jan 2013); Vol. 6, Issue 1; Treatment of cutaneous lupus erythematosus: review and assessment of treatment benefits based on Oxford Centre for Evidence-based Medicine criteria; pg. 27-38
  • The Kurume Medical Journal (1999); Vol. 46, Issue 1; Envoplakin and periplakin are the paraneoplastic pemphigus antigens; pg. 71-78
  • The New England Journal of Medicine (Aug 2022); Vol. 387, Issue 7; Albuterol-budesonide fixed-dose combination rescue inhaler for asthma; pg. 662-663